Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation

Brain Research

Volumn 953, Issue 1-2, 2002, Pages 135-143

  Lüth, Hans Joachim ^a   Münch, Gerald ^b   Arendt, Thomas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Alzheimer's disease; Nitric oxide synthase; Nitrotyrosine

Indexed keywords

3 NITROTYROSINE; NITRIC OXIDE SYNTHASE;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN BLOOD VESSEL; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; ENDOTHELIUM; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NERVE CELL; NERVE CELL NETWORK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SYNTHESIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; FEMALE; HUMANS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PEROXYNITROUS ACID; PYRAMIDAL CELLS; TYROSINE;

EID: 0037145738     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03280-8     Document Type: Article

References (78)

1. Akama K.T., Van Eldik L.J. Beta-amyloid stimulation of inducible nitric oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase dependent signaling mechanism. J. Biol. Chem. 275:2000;7918-7924.
2. Akiyama H., Arai T., Kondo H., Tanno E., Haga C., Ikeda K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 14:(Suppl. 1):2000;47-53.
3. Barna M., Konatsu T., Reiss C.S. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology. 223:1996;331-343.
4. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272:1997;20313-20316.
5. Bolanos J.P., Peuchen S., Land J.M., Clark J.B., Heales S.J. Evaluation of the efficacy of potential therapeutic agents at protecting against nitric oxide synthase-mediated mitochondrial damage in activated astrocytes. Brain Res. Protoc. 3:1997;258-262.
6. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 31:1999;577-596.
7. Calingasan N.Y., Chun W.J., Park L.C., Uchida K., Gibson G.E. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency. J. Neuropathol. Exp. Neurol. 58:1999;946-958.
8. Chao C.C., Hu S., Sheng W.S., Bu D., Bukrinsky M.I., Peterson P.K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
9. Clementi F., Dolly O.J., Onali P., Bagetta G. Neurotoxins in neurobiology: from basic research to clinical application. Toxicon. 36:1998;2043-2046.
10. Dawson T.M., Snyder S.H. Gases as biological messenger: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:1994;5147-5159.
11. Dawson V.L., Dawson T.M. Nitric oxide in neurodegeneration. Prog. Brain Res. 118:1998;215-229.
12. Dawson T.M., Sasaki M., Gonzales-Zulueta M., Dawson V.L. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways. Prog. Brain Res. 118:1998;3-11.
13. Dinerman J.L., Dawson T.M., Schell M.J., Snowman A., Snyder S.H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl. Acad. Sci. USA. 10:1994;4214-4218.
14. Dorheim M.A., Tracy W.R., Pollock J.S., Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205:1994;659-665.
15. Doyle C.A., Slater P. Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus. Neuroscience. 76:1997;387-395.
16. Endoh M., Maiese K., Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651:1994;92-100.
17. Ferrante R.J., Hantraye P., Brouillet E., Beal M.F. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase. Brain Res. 823:1999;177-182.
18. Fischer H.C., Kuljis R.O. Multiple types of nitrogen monoxide synthase/NADPH diaphorase-containing neurons in the human neocortex. Brain Res. 654:1994;105-117.
19. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Med. 222:1999;236-245.
20. Förstermann U., Kleinert H. Nitric oxide synthase expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch. Pharmacol. 352:1995;351-364.
21. Förstermann U., Gath I., Schwarz P., Closs E.I., Kleinert H. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem. Pharmacol. 50:1995;1321-1332.
22. Gabbott P.L., Bacon S.J. Localisation of NADPH diaphorase activity and NOS immunoreactivity in astroglia in normal adult rat brain. Brain Res. 714:1996;135-144.
23. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 19:1971;1-8.
24. Good P.F., Hsu A., Werner P., Perl D.P., Olanow C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57:1998;338-342.
25. Goureau O., Regnier-Ricard F., Courtois Y. Requirement for nitric oxide in retinal neuronal cell death induced by activated Muller glial cells. J. Neurochem. 72:1999;2506-2515.
26. Greenberg S.G., Davies P., Schein J.D., Binder L.I. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267:1929;564-569.
27. Griffin W.S., Stanley C., Ling C., White L. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
28. Hensley K., Maidt M.L., Yu Z.Q., Sang H., Markesbery W.R., Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18:1998;8126-8132.
29. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 28:2000;1456-1462.
30. Hölscher Ch. Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homoeostasis. Neurobiology. 5:1998;129-141.
31. Hu J., el-Fakahany E.E. Beta-amyloid 25-35 activates nitric oxide synthase in a neuronal clone. Neuroreport. 4:1993;760-762.
32. Hu J., Akama K.T., Krafft G.A., Chromy B.A., Van Eldik L.J. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785:1998;195-206.
33. Hunot S., Boissiere F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., Hirsch E.C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience. 72:1996;355-363.
34. Iadecola C., Zhang F., Xu S., Casey R., Rosse M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;378-384.
35. Iravani M.M., Kashefi K., Mander P., Rose S., Jenner P. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience. 110:2002;49-58.
36. Iwase K., Miyanaka K., Shimizu A., Nagasaki A., Gotoh T., Mori M., Takiguchi M. Induction of endothelial nitric oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment. J. Biol. Chem. 275:2000;11929-11933.
37. Johnstone M., Gearing A.J., Miller K.M. A central role for astrocytes in the inflammatory response to beta-amyloid: chemokines, cytokines and reactive oxygen species are produced. J. Neuroimmunol. 93:1999;182-193.
38. Khatchaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
39. Kirsch M., Korth H.G., Sustmann R., de Groot H. The pathobiochemistry of nitrogen dioxide. Biol. Chem. 383:2002;389-399.
40. Law A., Gauthier S., Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Rev. 35:2001;73-96.
41. Lee S.C., Brosnan C.F. Cytokine regulation of iNOS expression in human glial cells. Methods. 10:1996;31-37.
42. Lee S.C., Dickson D.W., Brosnan C.F. Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav. Immun. 9:1995;345-354.
43. Lüth H.J. Ultrastructural demonstration of constitutive nitric oxide synthase (cNOS) in neocortical glial cells and glial perisynaptic sheaths. Ann. Anat. 179:1997;221-225.
44. Lüth H.J., Arendt Th. Co-expression of APP with cNOS but not iNOS after cortical injury in rat. Neuroreport. 8:1997;2321-2324.
45. Lüth H.J., Arendt Th. Nitric oxide and Alzheimer's disease. J. Brain Res. 39:1998;245-251.
46. Lüth H.J., Hedlich A., Hilbig H., Winkelmann E., Mayer B. Morphological analyses of NADPH-diaphorase/nitric oxide synthase positive structures in human visual cortex. J. Neurocytol. 23:1994;770-782.
47. Lüth H.J., Holzer M., Gertz H.J., Arendt Th. Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21 ras and p16INK4a. Brain Res. 852:2000;45-55.
48. Lüth H.J., Holzer M., Gärtner U., Staufenbiel M., Arendt Th. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP 23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 913:2001;57-67.
49. McKhann G., Drachmann D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;934-944.
50. Mollace V., Nistico G. Release of nitric oxide from astroglial cells: a key mechanism in neuroimmune disorders. Adv. Neuroimmunol. 5:1995;421-430.
51. Moncada S. Nitric oxide: discovery and impact on clinical medicine. J. R. Soc. Med. 92:1992;164-169.
52. Monford J.C., Javoy-Agid F., Hauw J., Dubois B., Agid Y. Brain glutamate decarboxylase in Parkinson's disease with particular reference to premortem severity index. Brain. 108:1985;301-313.
53. Murphy S. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia. 29:2000;1-13.
54. Norris P.J., Faull R.L.M., Emson P.C. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. Mol. Brain Res. 41:1996;36-49.
55. Park S.K., Murphy S. Duration of expression of inducible nitric oxide synthase in glial cells. J. Neurosci. Res. 39:1994;405-411.
56. Patterson P.H. Cytokines in Alzheimer's disease and multiple sclerosis. Curr. Opin. Neurobiol. 5:1995;642-646.
57. Perry H., Bell D., Brown C., Matyszak K. Inflammation in the nervous system. Curr. Opin. Neurobiol. 5:1995;618-641. review.
58. Rossi F., Bianchini E. Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225:1996;474-478.
59. Rothwell N.J., Luheshi G.N. Interleukin I in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23:2000;618-625.
60. Schmidt H.H.H.W., Walter U. NO at work. Cell. 78:1994;919-925.
61. Schulz J.B., Matthews R.T., Beal M.F. Role of nitric oxide in neurodegenerative diseases. Curr. Opin. Neurol. 8:1995;480-486.
62. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 15:1997;2653-2657.
63. Sohn Y.K., Ganju N., Bloch K.D., Wands J.R., de la Monte S.M. Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative disease. J. Neurol. Sci. 162:1999;133-151.
64. Thorns V., Hansen L., Masliah E. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp. Neurol. 150:1998;14-20.
65. Torreilles F., Salman-Tabcheh S., Guerin M.C., Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Rev. 30:1999;153-163.
66. Urushitani M., Shimohama S. The role of nitric oxide in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2:2001;71-81.
67. Vincent V.A., Tilders F.J., Van Dam A.M. Production, regulation and role of nitric oxide in glial cells. Mediators Inflamm. 7:1998;239-255.
68. Vodovotz Y., Lucia M.S., Flanders K.C., Chesler L., Xie Q., Smith T.W., Weidner F., Mumford R., Webber R., Nathan C., Roberts A.B., Lippa C.F., Sporn M.B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184:1996;1425-1433.
69. Wallace M.N., Bisland S.K. NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase. Neuroscience. 59:1994;905-919.
70. Wallace M.N., Tayebjee M.H., Rana F.S., Farquhar D.A., Nyong'o A.O. Pyramidal neurons in pathological human cortex express nitric oxide synthase. Neurosci. Lett. 212:1996;187-190.
71. Wallace M.N., Geddes J.G., Farquhar D.A., Masson M.R. Nitric oxide synthase in reactive astrocytes adjacent to β-amyloid plaques. Exp. Neurol. 144:1997;266-272.
72. Wiencken A.E., Casagrande V.A. Endothelial nitric oxide synthase (eNOS) in astrocytes: another source of nitric oxide in neocortex. Glia. 26:1999;280-290.
73. Williamson K.S., Gabbita S.P., Mou S., West M., Pye Q.N., Markesbery W.R., Cooney R.V., Grammas P., Reimann-Philipp U., Floyd R.A., Hensley K. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide: Biol. Chem. 6:2002;221-227.
74. Wilson R.I., Yanovsky J., Godecke A., Stevens D.R., Schrader J., Haas H.L. Endothelial nitric oxide synthase and LTP. Nature. 386:1997;338-339.
75. Wong A., Lüth H.J., Deuther-Conrad W., Dukic-Stefanovic S., Gasic-Milenkovic J., Arendt Th., Münch G. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res. 920:2001;32-40.
76. Yew D.T., Wong H.W., Li W.P., Lai H.W., Yu W.H. Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains. Neuroscience. 89:1999;675-686.
77. de la Monte S.M., Bloch K.D. Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer disease. Mol. Chem. Neuropathol. 30:1997;139-159.
78. de la Monte S.M., Lu B.X., Sohn Y.K., Etienne D., Kraft J., Ganju N., Wands J.R. Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration. Neurobiol. Aging. 21:2000;309-319.